Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




New WHO Tools Address Gaps in Antimicrobial Resistance Testing

By LabMedica International staff writers
Posted on 17 Nov 2026

Antimicrobial resistance (AMR) is a growing global health threat, making infections increasingly difficult to diagnose and treat as they become resistant to standard antibiotics. More...

Its spread is driven partly by antibiotic use in human healthcare, animal husbandry, and food production, contributing to infectious disease mortality worldwide. Despite the urgent need for effective prevention, accurate diagnostics, and responsible antibiotic use, new findings indicate that progress remains too slow to meet global targets.

The World Health Organization (WHO) has released two new tools intended to help countries strengthen diagnostic capacity for antimicrobial resistance. The first tool defines the tests that should be available across health care settings, from primary care centers to referral hospitals. The second compiles 73 laboratory procedures covering sample collection, pathogen identification and antibiotic susceptibility testing.

The tools were announced after a WHO investigation across 183 countries assessed progress in combating antimicrobial resistance. Nearly nine in 10 countries reported having a national action plan, compared with around four in 10 in 2017. However, only 42 countries reported having a plan that was financed, implemented and monitored.

Diagnostic access remains a major weakness in the response. Only 36% of countries had a national reference laboratory capable of testing for resistance in all bacteria and fungi monitored by WHO, compared with an 80% target for 2030. WHO also stated that 2023 global surveillance data showed one in every six laboratory-confirmed bacterial infections reported to the agency was resistant to antibiotics used for treatment. The agency estimated that antimicrobial resistance could cause about 39 million deaths between now and 2050.

“Antimicrobial resistance is widespread and threatening the future of modern medicine,” said Jean-Pierre Nyemazi, interim head of antimicrobial resistance at the WHO. “Unlike COVID-19, which was very visible, drug-resistant infections have been taking people's lives for years without us noticing it and raising the alarm as we should.”

“Countries are moving forward in every step, but progress still needs to be speeded up to reach the 2030 targets,” added Nyemazi.

Related Links
World Health Organization


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.